Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S GOLD

Showing results (1141-1150 of 1,175) with videos related to

Pageof 118
Sort By:
Pain Medicine (Malden, Mass.)|February 17, 2021
Providing Epidemiological Data in Lumbar Spine Imaging Reports Did Not Affect Subsequent Utilization of Spine Procedures: Secondary Outcomes from a Stepped-Wedge Randomized Controlled TrialPradeep Suri, Eric N Meier, Laura S Gold, et al.
Acta Scientific Neurology|June 10, 2026
Opioid-Induced Nodding-Not a Nice NapKenneth Blum, Alireza Sharafshah, Kyriaki Thanos, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 16, 2022
Seafood-induced anaphylaxis in children presenting to Canadian emergency departments: Rates, clinical presentation, and managementDaniel Sehayek, Morgan S Gold, Sofianne Gabrielli, et al.
Leukemia|August 22, 2015
Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myelomaR H Prabhala, M Fulciniti, D Pelluru, et al.
Gene & Protein in Disease|August 1, 2025
Exploring dopamine as the master regulator of brain circuitry and mental health genomeKenneth Blum, Eric R Braverman, Alireza Sharafshah, et al.
Psychology Research and Behavior Management|December 5, 2023
Neurogenetics and Epigenetics of LonelinessAbdalla Bowirrat, Igor Elman, Catherine A Dennen, et al.
Neurology (E-Cronicon)|September 29, 2025
Multi-Locus Pro-Dopaminergic Restoration of Reward Brain Circuitry in Reward Deficiency Rescinds Mono-Pharmaceutical TargetingKenneth Blum, Kavya Mohankumar, Debasis Bagchi, et al.
Journal of Medicinal Chemistry|July 1, 2025
Thioquinazolinones as Antituberculosis Agents Targeting Phosphopantetheinyl TransferaseAmrita Singh, Logan T Zwerneman, Kyle Planck, et al.
Open Journal of Immunology|November 7, 2024
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial TherapiesKenneth Blum, Igor Elman, David Han, et al.
Frontiers in Public Health|December 3, 2025
Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergiaKai-Uwe Lewandrowski, Kenneth Blum, Alexander P L Lewandrowski, et al.
Pageof 118

Showing results (1141-1150 of 1,175) with videos related to

Sort By:
Pageof 118
Pain Medicine (Malden, Mass.)|February 17, 2021
Providing Epidemiological Data in Lumbar Spine Imaging Reports Did Not Affect Subsequent Utilization of Spine Procedures: Secondary Outcomes from a Stepped-Wedge Randomized Controlled TrialPradeep Suri, Eric N Meier, Laura S Gold, et al.
Acta Scientific Neurology|June 10, 2026
Opioid-Induced Nodding-Not a Nice NapKenneth Blum, Alireza Sharafshah, Kyriaki Thanos, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 16, 2022
Seafood-induced anaphylaxis in children presenting to Canadian emergency departments: Rates, clinical presentation, and managementDaniel Sehayek, Morgan S Gold, Sofianne Gabrielli, et al.
Leukemia|August 22, 2015
Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myelomaR H Prabhala, M Fulciniti, D Pelluru, et al.
Gene & Protein in Disease|August 1, 2025
Exploring dopamine as the master regulator of brain circuitry and mental health genomeKenneth Blum, Eric R Braverman, Alireza Sharafshah, et al.
Psychology Research and Behavior Management|December 5, 2023
Neurogenetics and Epigenetics of LonelinessAbdalla Bowirrat, Igor Elman, Catherine A Dennen, et al.
Neurology (E-Cronicon)|September 29, 2025
Multi-Locus Pro-Dopaminergic Restoration of Reward Brain Circuitry in Reward Deficiency Rescinds Mono-Pharmaceutical TargetingKenneth Blum, Kavya Mohankumar, Debasis Bagchi, et al.
Journal of Medicinal Chemistry|July 1, 2025
Thioquinazolinones as Antituberculosis Agents Targeting Phosphopantetheinyl TransferaseAmrita Singh, Logan T Zwerneman, Kyle Planck, et al.
Open Journal of Immunology|November 7, 2024
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial TherapiesKenneth Blum, Igor Elman, David Han, et al.
Frontiers in Public Health|December 3, 2025
Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergiaKai-Uwe Lewandrowski, Kenneth Blum, Alexander P L Lewandrowski, et al.
Pageof 118